Longeveron LGVN
NASDAQ LGVN
$0.84 +0.02 (+2.02%)
At close: Aug 21, 2026 · 4:00 PM EDT

Longeveron (LGVN) Invested Capital (2021 - 2023)

Longeveron (LGVN) posted quarterly Invested Capital of $586000.0 for Q3 2023, up 1.38% quarter-over-quarter from $578000.0 in Q2 2023.

Longeveron (LGVN) Invested Capital (2021 - 2023) Analysis & Trends

Longeveron's Invested Capital history runs 3 years deep, the most recent figure standing at $586000.0 for Q3 2023.

  • In Q3 2023, Invested Capital changed N/A year-over-year to $586000.0; the TTM figure through Jun 2024 stood at $586000.0 (down 87.02% YoY), while the FY2022 annual figure was $2.0 million, down 21.65% from the prior year.
  • Invested Capital for Q3 2023 stood at $586000.0, up from $578000.0 in the prior quarter.
  • The five-year high for Invested Capital was $2.6 million in Q4 2021, with the low at $578000.0 in Q2 2023.
  • The 3-year median for Invested Capital is $1.9 million (2023), against an average of $1.5 million.
  • Peak annual rise in Invested Capital reached 21.65% in 2022, while the deepest fall reached 21.65% in 2022.
  • Longeveron's Invested Capital stood at $2.6 million in 2021, then retreated by 21.65% to $2.0 million in 2022, then plunged by 71.29% to $586000.0 in 2023.
  • Business Quant data shows LGVN's Invested Capital at $586000.0 in Q3 2023, $578000.0 in Q2 2023, and $1.9 million in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 37.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 190.90 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 1.45 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - 380.00 Mn
10 Longeveron 26.51 Mn 16.41 Mn 182,000.00 -

Historic Data

Download Data
DateValue
Sep 30, 2023 586,000.00
Jun 30, 2023 578,000.00
Mar 31, 2023 1.90 Mn
Dec 31, 2022 2.04 Mn
Dec 31, 2021 2.61 Mn